Diseases, Conditions, Syndromes

We have a vaccine for hepatitis B, but we still need a cure

Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a life-long infection. This includes 240,000 Australians, ...

Diseases, Conditions, Syndromes

How the hepatitis B virus establishes persistent infection

New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...

Diseases, Conditions, Syndromes

Push to cure hepatitis B, a neglected disease

A coalition of researchers, health organisations and patient groups on Wednesday launched an ambitious campaign to cure hepatitis B, a disease that kills twice as many people as malaria but gets far less attention.

Medications

First two-drug regimen approved for HIV-1 treatment

(HealthDay)—The U.S. Food and Drug Administration has announced the approval of Dovato (dolutegravir and lamivudine), the first approved two-drug, fixed-dose, complete regimen for adults with HIV-1 who have not been previously ...

Diseases, Conditions, Syndromes

Slight decline in hepatitis C diagnoses in Europe

European surveillance data show a 10 percent decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union ...

page 6 from 16